Ramsay Health Care (ASX:RHC) Growth Rank: 8 (As of Jul. 27, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:RHC Ramsay Health Care Ltd ASX:RHC
86 GF Score
Price A$42.54
GF Value A$50.70
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Ramsay Health Care Growth Rank?

Ramsay Health Care ASX:RHC +0.57% 86 Growth Rank is 8 as of Jul. 27, 2026, which is at its 10-year median of 8.00. GuruFocus rates ASX:RHC with a GF Score™ of 86/100 and a GF Value™ of A$50.70 (Modestly Undervalued). The stock has 9 warning signs investors should review.

Ramsay Health Care has the Growth Rank of 8.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Ramsay Health Care Growth Rank Related Terms

ASX:RHC vs HCA, THC, DVA: Growth Rank Comparison

For the Medical Care Facilities subindustry, Ramsay Health Care's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ramsay Health Care Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ramsay Health Care's Growth Rank distribution charts can be found below:

* The bar in red indicates where Ramsay Health Care's Growth Rank falls into.


ASX:RHC
86GF Score
Ramsay Health Care Ltd ASX:RHC
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 8 mean?
Ramsay Health Care (ASX:RHC) has a Growth Rank of 8 as of Jul. 27, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Ramsay Health Care and its competitors. This is near median its historical median of 8.00. Over the past decade, Ramsay Health Care's Growth Rank has ranged from 4.00 to 10.00.
Is Ramsay Health Care's Growth Rank too high?
Ramsay Health Care's current Growth Rank of 8 is near median its 10-year median of 8.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 10.00. Overall, Ramsay Health Care has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ramsay Health Care's Growth Rank compare to HCA and THC?
Ramsay Health Care's Growth Rank of 8 can be compared against companies in the Healthcare Providers & Services industry. Historically, Ramsay Health Care's own Growth Rank has ranged from 4.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Ramsay Health Care and its competitors. Ramsay Health Care's current Growth Rank is 8, which is near median its own 10-year median of 8.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Health Care stock overvalued right now?
Based on GuruFocus' analysis, Ramsay Health Care (ASX:RHC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$50.70, compared to a current price of A$42.54 — trading 16.1% below its estimated fair value. The current Growth Rank is 8, which is near median its 10-year median of 8.00. Ramsay Health Care's overall GF Score™ is 86/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Ramsay Health Care (ASX:RHC), the current Growth Rank is 8 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ramsay Health Care (ASX:RHC) Overvalued in 2026?

Based on GuruFocus' analysis, Ramsay Health Care stock appears to be undervalued. The current stock price of A$42.54 is trading 16.1% below its estimated GF Value™ of A$50.70. GuruFocus considers Ramsay Health Care to be Modestly Undervalued.

Key valuation signals for ASX:RHC:

  • Growth Rank: 8 (near median its 10-year median of 8.00)
  • GF Value™: A$50.70 vs. price of A$42.54 (16.1% below fair value)
  • GF Score™: 86/100 with 9 warning signs

No single metric tells the full story. See the ASX:RHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ramsay Health Care Business Description

Address 126 Phillip Street, Suite 18.03, Level 18, Deutsche Bank Place, Sydney, NSW, AUS, 2000
Ramsay Health Care is one of the largest private healthcare providers in the world, with more than 500 sites across about eight countries. The key markets in which it operates are Australia, France, the UK, and Sweden. It is the largest private hospital group in each of these markets except for the UK, where it is the largest independent supplier to the NHS. Ramsay Santé, which operates the European regions other than the UK, is a 53%-owned subsidiary of Ramsay Health Care. The company typically earns about two-thirds of consolidated earnings in Australia. Ramsay Health Care undertakes both private and publicly funded healthcare.
86GF Score

Get the complete analysis for ASX:RHC

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$42.54
Price
A$50.70
GF Value